U.S. RESEARCH ROUNDUP-Linkbancorp, Oyster Point Pharma, Viatris

Clover Health Investments

08/11/2022 07:38

Nov 8 (Reuters) - Wall Street securities analysts revised their ratings and price
targets on several U.S.-listed companies, including Linkbancorp, Oyster Point Pharma and
Viatris, on Tuesday. 
    HIGHLIGHTS
                 * Amgen Inc  AMGN.O : Truist Securities raises target price to $280 from $266 
 
                 * Linkbancorp Inc  LNKB.O : Stephens cuts to equal-weight from overweight 
 
                 * Oyster Point Pharma Inc  OYST.O : Piper Sandler cuts to neutral from overweight     
 
                 * Univest Financial Corp  UVSP.O : Stephens cuts to equal-weight from overweight     
 
                 * Viatris Inc  VTRS.O : Piper Sandler raises to neutral from underweight
 
 Following is a summary of research actions on U.S. companies reported by Reuters on Tuesday.
Stock entries are in alphabetical order. 
                 * 23Andme Holding Co.  ME.O : Credit Suisse cuts target price to $6 from $7 
 
                 * Aaon Inc  AAON.O : D.A. Davidson raises target price to $75 from $72 
 
                 * Affiliated Managers Group Inc  AMG.N : Barrington Research raises target to $155 from
 $145 
 
                 * Affiliated Managers Group Inc  AMG.N : Credit Suisse raises target to $163.5 from $140 
 
                 * Akoya Biosciences Inc  AKYA.O : BTIG cuts target price to $18 from $20 
 
                 * Albemarle Corp  ALB.N : RBC raises target price to $380 from $371 
 
                 * Alight Inc  ALIT.N : Credit Suisse raises target price to $13 from $12 
 
                 * Allakos Inc  ALLK.O : Jefferies raises target price to $7 from $4.5 
 
                 * Allovir Inc  ALVR.O : JP Morgan cuts target price to $23 from $25 
 
                 * Amgen Inc  AMGN.O : Jefferies raises target price to $325 from $300 
 
                 * Amgen Inc  AMGN.O : Truist Securities raises target price to $280 from $266 
 
                 * Apellis Pharmaceuticals Inc  APLS.O : Credit Suisse cuts target price to $43 from $45 
 
                 * Apellis Pharmaceuticals Inc  APLS.O : Jefferies cuts target price to $70 from $80 
 
                 * Applied Molecular Transport Inc.  AMTI.O : SVB Securities cuts target to $15 from $21 
 
                 * Applovin Corp  APP.O : Credit Suisse cuts target price to $63 from $80 
 
                 * Ashland Global Holdings Inc  ASH.N : Credit Suisse raises target price to $125 from
 $120 
 
                 * Avalonbay Communities Inc  AVB.N : RBC cuts target price to $196 from $210 
 
                 * Beacon Roofing Supply Inc  BECN.O : JP Morgan raises target price to $60 from $59 
 
                 * Beam Therapeutics Inc  BEAM.O : Credit Suisse cuts target price to $53 from $65 
 
                 * Beam Therapeutics Inc  BEAM.O : JP Morgan cuts target price to $99 from $102 
 
                 * Beam Therapeutics Inc  BEAM.O : RBC cuts target price to $60 from $76 
 
                 * Beam Therapeutics Inc  BEAM.O : Wedbush cuts target price to $79 from $100 
 
                 * Block Inc  SQ.N : Stephens cuts target price to $75 from $110 
 
                 * Bluebird Bio Inc  BLUE.O : RBC cuts target price to $8 from $10 
 
                 * Boston Properties Inc  BXP.N : JP Morgan cuts target price to $76 from $103 
 
                 * Brandywine Realty Trust  BDN.N : JP Morgan cuts target price to $10 from $11 
 
                 * Broadmark Realty Capital Inc  BRMK.N : Piper Sandler cuts target price to $5 from $5.5 
 
                 * Brp Group Inc  BRP.O : JP Morgan raises target price to $31 from $30 
 
                 * Cactus Inc  WHD.N : Piper Sandler raises target price to $52 from $47 
 
                 * Cara Therapeutics Inc  CARA.O : Piper Sandler cuts target price to $25 from $30 
 
                 * Caredx Inc  CDNA.O : Raymond James cuts target price to $26 from $35 
 
                 * Caredx Inc  CDNA.O : Stephens cuts target price to $21 from $38 
 
                 * Carvana Co  CVNA.N : JP Morgan cuts target price to $10 from $20 
 
                 * CBOE Global Markets Inc  CBOE.Z : JP Morgan raises target price to $131 from $120 
 
                 * Celanese Corp  CE.N : RBC cuts target price to $98 from $100 
 
                 * Choice Hotels International Inc  CHH.N : JP Morgan cuts target price to $108 from $114 
 
                 * Cigna Corp  CI.N : SVB Securities raises target price to $335 from $305 
 
                 * Clover Health Investments Corp  CLOV.O : SVB Securities cuts target price to $1.5 from
 $3 
 
                 * Cogent Communications Holdings Inc  CCOI.O : Credit Suisse raises target to $57 from
 $56 
 
                 * Concert Pharmaceuticals Inc  CNCE.O : Jefferies raises target price to $15 from $14 
 
                 * CVR Energy Inc  CVI.N : JP Morgan cuts target price to $30 from $33 
 
                 * Definitive Healthcare Corp  DH.O : Jefferies cuts target price to $16 from $31 
 
                 * Delek US Holdings Inc  DK.N : Raymond James raises target price to $39 from $37 
 
                 * Dermtech Inc  DMTK.O : BTIG cuts target price to $6 from $15 
 
                 * Diamondback Energy Inc  FANG.O : Credit Suisse raises target price to $190 from $180 
 
                 * Digitalbridge Group Inc  DBRG.N : JP Morgan cuts target price to $20 from $28 
 
                 * Digitalocean Holdings Inc  DOCN.N : Oppenheimer cuts target price to $40 from $65 
 
                 * Digitalocean Holdings Inc  DOCN.N : Piper Sandler cuts target price to $39 from $57 
 
                 * Diodes Inc  DIOD.O : Wells Fargo raises target price to $75 from $70 
 
                 * Exact Sciences Corp  EXAS.O : Raymond James cuts target price to $60 from $70 
 
                 * Fibrogen Inc  FGEN.O : Stifel cuts target price to $23 from $25 
 
                 * First Foundation Inc  FFWM.O : Piper Sandler cuts target price to $17.5 from $24 
 
                 * First Watch Restaurant Group Inc  FWRG.O : Cowen and Company cuts target to $17 from
 $18.5 
 
                 * Five9 Inc  FIVN.O : Moffettnathanson cuts target price to $60 from $100 
 
                 * Five9 Inc  FIVN.O : Piper Sandler cuts target price to $61 from $77 
 
                 * Freshpet Inc  FRPT.O : Oppenheimer raises target price to $80 from $65 
 
                 * G1 Therapeutics Inc  GTHX.O : JP Morgan cuts target price to $7 from $14 
 
                 * Graftech International Ltd  EAF.N : RBC cuts target price to $4 from $7 
 
                 * Groupon Inc  GRPN.O : Credit Suisse cuts target price to $15 from $18 
 
                 * Hcw Biologics Inc  HCWB.O : Jonestrading initiates with buy rating and $8 target price 
 
                 * Helios Technologies Inc  HLIO.N : Stifel cuts target price to $59 from $71 
 
                 * Hershey Co  HSY.N : JP Morgan raises target price to $216 from $210 
 
                 * Iaa Inc  IAA.N : Jefferies cuts to hold from buy; cuts target price to $40 from $55 
 
                 * Iheartmedia Inc  IHRT.O : Barrington Research cuts target price to $13 from $18 
 
                 * Ikena Oncology Inc  IKNA.O : Credit Suisse cuts target price to $18 from $20 
 
                 * Inhibrx Inc  INBX.O : Credit Suisse cuts target price to $46 from $48 
 
                 * International Flavors & Fragrances Inc  IFF.N : Credit Suisse cuts PT to $130 from $145
 
                 * Invacare Corp  IVC.N : Oppenheimer cuts target price to $2 from $5.5 
 
                 * Kaleyra Inc  KLR.N : Oppenheimer cuts target price to $2 from $6 
 
                 * Krystal Biotech Inc  KRYS.O : Chardan Capital Markets raises target to $133 from $130 
 
                 * Leidos Holdings Inc  LDOS.N : Wells Fargo raises target price to $114 from $105 
 
                 * Linkbancorp Inc  LNKB.O : Stephens cuts to equal-weight from overweight 
 
                 * Macom Technology Solutions Holdings Inc  MTSI.O : Jefferies raises target to $72 from
 $59 
 
                 * Malibu Boats Inc  MBUU.O : D.A. Davidson cuts target price to $48 from $50 
 
                 * Meridianlink Inc  MLNK.N : Credit Suisse cuts target price to $16 from $17 
 
                 * Nanostring Technologies Inc  NSTG.O : Cowen and Company cuts target price to $24 from
 $31 
 
                 * Ocular Therapeutix Inc  OCUL.O : Jefferies cuts target price to $5 from $6.5 
 
                 * Oyster Point Pharma Inc  OYST.O : Piper Sandler cuts target price to $11 from $15 
 
                 * Oyster Point Pharma Inc  OYST.O : Piper Sandler cuts to neutral from overweight 
 
                 * Palantir Technologies Inc  PLTR.N : RBC cuts target price to $5 from $6 
 
                 * PayPal Holdings Inc  PYPL.O : Jefferies cuts target price to $75 from $93 
 
                 * Powerschool Holdings Inc  PWSC.N : Piper Sandler raises target price to $22 from $19 
 
                 * Primo Water Corp  PRMW.N : JP Morgan cuts target price to $18 from $19 
 
                 * Q2 Holdings Inc  QTWO.N : Raymond James cuts target price to $45 from $65 
 
                 * Q2 Holdings Inc  QTWO.N : RBC cuts target price to $32 from $38 
 
                 * Rallybio Corp  RLYB.O : Jefferies cuts target price to $19 from $20 
 
                 * Replimune Group Inc  REPL.O : JP Morgan raises target price to $34 from $33 
 
                 * Rithm Capital Corp  RITM.N : Wedbush cuts target price to $12 from $12.5 
 
                 * Rocket Companies Inc  RKT.N : Credit Suisse cuts target price to $7 from $9 
 
                 * Rxsight Inc  RXST.O : JP Morgan raises target price to $22 from $17 
 
                 * Schlumberger NV  SLB.N : RBC raises target price to $66 from $59 
 
                 * Shift4 Payments Inc  FOUR.N : RBC cuts target price to $57 from $65 
 
                 * Si-Bone Inc  SIBN.O : Truist Securities cuts target price to $20 from $22 
 
                 * Stepstone Group Inc  STEP.O : JP Morgan raises target price to $37 from $36 
 
                 * Take-Two Interactive Software Inc  TTWO.O : JP Morgan cuts target price to $144 from
 $165 
 
                 * Teradata Corp  TDC.N : Credit Suisse cuts target price to $30 from $35 
 
                 * Teradata Corp  TDC.N : RBC cuts target price to $37 from $38 
 
                 * Tyra Biosciences Inc  TYRA.O : Jefferies cuts target price to $25 from $26 
 
                 * Unity Software Inc  U.N : Credit Suisse cuts target price to $85 from $105 
 
                 * Univest Financial Corp  UVSP.O : Stephens cuts to equal-weight from overweight 
 
                 * US Xpress Enterprises Inc  USX.N : Stephens cuts target price to $3.3 from $3.5 
 
                 * Vaxcyte Inc  PCVX.O : Cantor Fitzgerald raises target price to $70 from $55 
 
                 * Veeco Instruments Inc  VECO.O : Oppenheimer cuts target price to $25 from $30 
 
                 * Verra Mobility Corp  VRRM.O : Credit Suisse cuts target price to $18 from $19 
 
                 * Verve Therapeutics Inc  VERV.O : Credit Suisse cuts target price to $37 from $48 
 
                 * Verve Therapeutics Inc  VERV.O : RBC cuts target price to $35 from $42 
 
                 * Viatris Inc  VTRS.O : Piper Sandler raises to neutral from underweight 
 
                 * Warner Bros Discovery Inc  WBD.O : Cowen and Company cuts target price to $17 from $24 
 
                 * WM Technology Inc  MAPS.O : Piper Sandler cuts target price to $3 from $4 
 
                 * Xencor Inc  XNCR.O : RBC cuts target price to $36 from $40 
 
 (Compiled by Bengaluru Newsroom; Editing by Dhanya Ann Thoppil)
 ((Diaries@thomsonreuters.com))